Bronx database sheds light on underdiagnosed heart condition in women and minorities

NCT ID NCT06257485

Ongoing Knowledge-focused Sponsor: Montefiore Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a database of 476 patients in the Bronx who were tested for transthyretin amyloid cardiomyopathy (ATTR-CM), a serious and often missed heart condition. Researchers collected health records, imaging results, and outcomes like hospitalizations and deaths. The goal is to better understand how ATTR-CM affects a racially and ethnically diverse group, including many women, who are often left out of similar studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could reveal how ATTR-CM affects women and diverse racial/ethnic groups, leading to better detection and care for these populations.
What could go wrong: This is an observational study, not a treatment trial. It only looks back at existing records, so it cannot prove cause and effect or test new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

wild type ATTR amyloidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TRANSTHYRETIN CARDIAC AMYLOIDOSIS

Contacts and locations

Locations

Montefiore Health System

The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.